Special Issue
Tumor growth and metastasis: molecular signaling and therapy
Submission Deadline: 31 December 2013
Articles: 7
Special Issue Editor
Guest Editor
Bin Ren
Research Associate, The Angiogenesis Research Center. Department of Medicine, Dartmouth Medical School, 1 Rope Ferry Road,Hanover, NH
Expertise: 30 publications, 2 grants, Editor of Frontiers in Bioscience
Manuscript Submission Information

Manuscripts should be submitted online at https://jour.ipublishment.com/bri by registering and logging into this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

Please visit the Instructions for Authors page before submitting a manuscript. Submitted papers should be well formatted and written in clear, concise English and should contain all essential data in order to make the presentation clear and the results of the study replicable. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see

here.

Keywords
Cancer, Cell Biology, Molecular Biology, Signaling, Therapeutics
Share This Special Issue
Published Papers (7 papers)
Open Access
Article
Chronic myeloid leukemia: why does it evolve from chronic phase to blast transformation?
Tariq I Mughal, John M Goldman
Frontiers in Bioscience-Landmark Volume 11 Issue 1, pp.198-208
Managing Editor: Bin Ren
DOI: 10.2741/1791 Published: 01 January 2006
Open Access
Article
Molecularly targeted treatment of chronic myeloid leukemia: beyond the imatinib era
Tariq I Mughal, John M Goldman
Frontiers in Bioscience-Landmark Volume 11 Issue 1, pp.209-220
Managing Editor: Bin Ren
DOI: 10.2741/1792 Published: 01 January 2006
Open Access
Review

Regulation of angiogenesis by phospholipid lysophosphatidic acid

Yiliang Chen, Devi Prasadh Ramakrishnan, Bin Ren
Frontiers in Bioscience-Landmark Volume 18 Issue 3, pp.852-861
Managing Editor: Bin Ren
DOI: 10.2741/4148 Published: 01 June 2013
Open Access
Article
Multiple signaling is involved in endostatin-mediated apoptosis in ECV 304 endothelial cells
Bin Ren, Yuan Wang, Kenneth Ndebele, Qiang Zhi, Fei-Hu Chen, Yu-Zhen Wang, Sareh Parangi
Frontiers in Bioscience-Landmark Volume 10 Issue 2, pp.1089-1097
Managing Editor: Bin Ren
DOI: 10.2741/1602 Published: 01 May 2005
Open Access
Article
The role of the tumor microenvironment in hematological malignancies and implication for therapy
Jianbiao Zhou, Katja Mauerer, Lucia Farina, John G Gribben
Frontiers in Bioscience-Landmark Volume 10 Issue 2, pp.1581-1596
Managing Editor: Bin Ren
DOI: 10.2741/1642 Published: 01 May 2005
Open Access
Article
Reactive oxygen species in tumor progression
Peter Storz
Frontiers in Bioscience-Landmark Volume 10 Issue 2, pp.1881-1896
Managing Editor: Bin Ren
DOI: 10.2741/1667 Published: 01 May 2005
Open Access
Article
Application of RNAi to cancer research and therapy
Fischer L Tan, James Q Yin
Frontiers in Bioscience-Landmark Volume 10 Issue 2, pp.1946-1960
Managing Editor: Bin Ren
DOI: 10.2741/1670 Published: 01 May 2005